Although no direct interventions in human models targeting Tip60 have been performed to date, the relevance of developing clinical trials targeting this HAT relies on the fact that Tip60 has been found to be upregulated in human tumor samples and associated with cancer progression and malignancy. This evidence concerns the gene KAT5 and cancer.